Zusammenfassung
Die Therapie der choroidalen Neovascularisation (CNV) bei Patienten mit feuchter Makuladegeneration entwickelte sich zur Anti-VEGF Therapie. Die peripapilläre CNV (PPCNV) ist eine andere Manifestation der CNV, die zusätzlich mittels chirurgischer Entfernung der Membranen behandelt werden kann. METHODIK: In dieser retrospektiven Studie wurde in 9 Augen von 9 Patienten evaluiert, ob es zu einer Verbesserung der morphologischen und visuellen Befunde durch die Operation kommt. RESULTATE: Die Operation war erfolgreich bei allen Patienten und das Sehvermögen blieb stabil oder verbesserte sich bei jedem Patienten um 2 oder mehr Linien. DISKUSSION: Folglich könnte die operative Entfernung der Membranen einen alternativen Ansatz in der Therapie von PPCNVs darstellen, obwohl nur eine kleine Anzahl an Patienten untersucht wurde. Randomisierte prospektive Studien sind erforderlich, die den Effekt von Operation oder Anti-VEGF Therapie allein oder in Kombination evaluieren.
Summary
The therapy of choroidal neovascularizations (CNVs) in wet age-related macular degeneration (AMD) developed to an anti-vascular endothelial growth factor (VEGF) therapy. Peripapilar CNV (PPCNV) represents another manifestation of CNV which may treated additionally by surgical extraction of the membranes. METHODS: In this retrospective study, the morphological and visual outcome after surgery of 9 eyes of 9 patients with PPCNV was evaluated. RESULTS: Surgery was successful in each patient and visual acuity remaind stable or improved in each patient by two or more lines. Recurrence was observed in 6 eyes within three years. DISCUSSION: Hence, surgery may represent an alternative approach in the therapy of PPCNV although only a small number of cases were included. Randomized prospective trials comparing surgical excision of PPCNV with anti-VEGF therapy alone or in combination are needed.
References
Cohen SY, Laroche A, Leguen Y, et al (1996) Etiology of choroidal neovascularization in younger patients. Ophthalmology 103: 1241–1244
Gass DM (1973) Drusen and disciform macular detachment and degeneration. Arch Ophthalmol 90: 201–217
Sarks SH (1976) Aging and degeneration in the macular region: a clinicopathologic study. Br J Ophthalmol 60: 324–341
Smiddy WE, Fine SL (1984) Prognosis of patients with bilateral macular drusen. Ophthalmology 92: 271–284
Green WR, McDonnell PJ, Yeo JH (1985) Pathologic features of senile macular degeneration 92: 615–627
Bressler SB, Bressler NM, Alexander J, Green WR (1992) Clinicopathologic correlation of occult choroidal neovascularization in age-related macular degeneration. Arch Ophthalmol 110: 827–832
Lim JI, Bressler NM, Marsh MJ, Bressler SB (1993) Laser treatment of choroidal neovascularization in patients with angioid streaks. Am J Ophthalmol 116: 414–423
Gass JD (1967) Pathogenesis of disciform detachment of the neuroepithelium. Am J Opthalmol 63 [Suppl]: 1–139
Kulkarni AD, Kuppermann BD (2005) Wet age-related macular degeneration. Adv Drug Delivery Rev 57: 1994–2009
Shams N, Iantschulev T (2006) Role of vascular endothelial growth factor in ocular angiogenesis. Ophthalmol Clin Nort Am 19: 335–344
Novack GD (2008) Pharmacotherapy for the treatment of choroidal neovascularization due to age-related macular degeneration. Ann Rev Pharmacol Toxicol 48: 61–78
Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, et al (2006) Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med 355: 1432–1444
Marsh MJ, Fine SL, Alexander J, et al (1995) Macular Photocoagulation Study Group. Laser Photocoagulation for neovascular lesions nasal to the fovea. Results from clinical trials for lesions secondary to ocular histoplasmosis or idiopathic causes. Arch Ophthalmol 113: 56–61
Cialdini AP, Jalkh AE, Trempe CL, et al (1989) Argon green laser treatment of peripapillary choroidal neovascular membranes. Ophthalmic Surg 20: 93–99
Turcotte P, Maguire MG, Fine SL (1991) Visual results after laser treatment for peripapillary choroidal neovascular membranes. Retina 11: 295–300
Flaxel CJ, Bird AC, Hamilton AM, et al (1996) Partial laser ablation of massive peripapillary subretinal neovascularization. Ophthalmology 103: 1250–1259
Rosenblatt BJ, Shah GK, Blinder K (2005) Photodynamic therapy with verteporfin for peripapillary choroidal neovascularization. Retina 25: 33–37
Bains HS, Patel MR, Singh H, Marcus DM (2003) Surgical treatment of extensive peripapillary choroidal neovascularization in elderly patients. Retina 23: 469–474
Kokame GT, Yamaoka S (2005) Subretinal surgery for peripapillary subretinal neovascular membranes. Retina 25: 564–569
Aisenbrey S, Gelisken F, Szurman P, Bartz-Schmidt KU (2007) Surgical treatment of peripapillary choroidal neovascularization. Br J Ophthalmol 91: 1027–1030
Almony A, Thomas MA, Atebara NH, Holekamp NM, Del Priore LV (2008) Long-term follow-up of surgical removal of extensive peripapillary choroidal neovascularization in presumed ocular histoplasmosis syndrome. Ophthalmology 115: 540–545
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Troger, J., Kralinger, M. & Kieselbach, G. Surgery for peripapillar choroidal neovascularization. Spektrum Augenheilkd. 22, 362–364 (2008). https://doi.org/10.1007/s00717-008-0295-4
Issue Date:
DOI: https://doi.org/10.1007/s00717-008-0295-4